Skip to main content
Addgene

INTRSECT Plasmid Collection


The development of powerful molecular reagents for biology have propelled our understanding of neural circuit functionality. Precisely expressing these tools in well-defined cellular sub-populations has generally been limited to single-component cellular definitions (e.g. neurons defined by a single gene or projection). Intersectional expression approaches combine multiplexed recombinases, including Cre, Flp, and VCre to enable viral expression of molecular payloads in target populations defined by multiple parameters.

A three part figure showing intersectional expression approaches. Part A shows three Venn-like diagrams depicting Cre AND Flp spheres with the overlapping area shaded, Cre NOT Flp spheres overlapping with the Cre area alone shaded, and finally Flp NOT Cre spheres with the Flp area alone shaded. Part B shows a three sphere overlap of Cre AND Flp AND VCre with only the overlapping area in the middle shaded. Part C shows six images of hippocampal slices, three at 500 micrometers and three at 50 micrometers. After injection with AAV-DJ-CON/FON-ChR2-eYFP, expression is only seen in the stratum oriens in PV-2a-Cre;SOM-IRES-Flp animals and not SOM-IRES-Flp or PV-2a-Cre animals.

Figure 1: Examples of intersectional cell population definitions using recombinases. A) Cre and Flp are multiplexed to enable intersectional viral targeting of populations expressing only Cre AND Flp, Cre NOT Flp, or Flp NOT Cre. B) This strategy has been expanded to incorporate VCre in order to enable three-feature cell targeting. C) Example of viral targeting of cells expressing Cre AND Flp, here expressed through a double transgenic animal strategy (PV-2a-Cre; SOM-IRES-Flp). Image from Fenno et al., 2014.

INTRSECT

INTRSECT (intronic recombinase sites enabling combinatorial targeting) is a synthetic molecular targeting strategy that allows adeno-associated virus (AAV)-borne payloads to be expressed in cells based on a doubly-specified combination of genetic and/or anatomical-defined parameters, by placing two orthogonal recombinase (Cre and Flp) recognition sequences within synthetic introns. INTRSECT was first shown as a proof-of-concept targeting approach in 2014 1 (using EYFP and ChR2-EYFP as payloads). This approach has been broadly applied using multiple recombinase-expression strategies to define cellular sub-populations of interest, including dual-transgenic recombinase-expressing mouse lines 2–9 and combinations of transgenic recombinase-expressing animal lines and retro-grade expressing viruses delivering additional recombinases 10–14.

A six part figure of the single (Parts A-C) and double (Parts D-F) intersectional constructs. Part A shows the three single intron intersectional constructs (each containing two orthogonal recombinase (Cre-dependent) recognition sequences flanking exon 1 and two orthogonal recombinase (Flp-dependent) recognition sequences flanking exon 2, with the four recognition sequences in the middle making up the intron): CON/FON (exon 1 (3’ to 5’), and exon 2 (3’ to 5’)), CON/FOFF (exon 1 (3’ to 5’), and exon 2), and COFF/FON (exon 1, and exon 2). Three example tool classes are also listed: fluorophores (ex. EYFP), GECIs (ex. GCaMP6m), and rabies glycoprotein (ex. OG). Part B shows each initial state (CON/FON, CON/FOFF, and COFF/FON,) with the addition of Cre and Flp, Cre, or Flp respectively leading to the directionally aligned exon 1 exon 2 active state. Addition of Cre leads to the COFF/FON inactivated state (exon 1 (3’ to 5’) exon 2) or the addition of Flp leads to the CON/FOFF inactivated state (exon 1 exon 2 (3’ to 5’). Part C shows the Cre-dependent and Flp-dependent parts of the construct as it moves from initial state to active state after recombinase activity (leaving single recognition sites flanking each exon), and from active state to mRNA after intron splicing (removing the intron made up of the two remaining recognition sites between the exons), and from mRNA to protein after translation. Part D shows the double intron intersection constructs (each containing two orthogonal recombinase (Cre-dependent) recognition sequences flanking exon 2 and two orthogonal recombinase (Flp-dependent) recognition sequences flanking all three exons, the two sets of recognition sequences between exons 3 and exons 2 make up intron 1 and the two sets of recognition sequences between exon 2 and exon 1 make up intron 2) CON/FON (exon 3 (3’ to 5’), exon 2, and exon 1 (3’ to 5’)), CON/FOFF (exon 3, exon 2 (3’ to 5’), and exon 1), and COFF/FON (exon 3 (3’ to 5’), exon 2 (3’ to 5’), and exon 1 (3’ to 5’)). Three example tool classes are also listed: Excitatory Opsins (ex. ChR2-EYFP), Inhibitory Opsins (ex. iC++-EYFP), and Rabies Glycoprotein (ex. TVA-mCherry). Part E shows each initial state (CON/FON, CON/FOFF, and COFF/FON,) with the addition of Cre and Flp, Cre, or Flp respectively leading to the directionally aligned exon 1 exon 2 exon 3 active state. With the addition of Cre we reach the COFF/FON inactivated state (exon 1 exon 2 (3’ to 5’) exon 3) or with the addition of Flp the CON/FOFF inactivated state (exon 3 (3’ to 5’)exon 2 (3’ to 5’) exon 1 (3’ to 5’)). Part F is similar to Part C but with the double introns.

Figure 2: INTRSECT works by inserting short, intronic sequences into the open reading frame (ORF) of a molecular tool and adding recombinase recognition sequences (e.g. Lox sites, FRT sites) inside of the introns (A,D). The addition of these recombinase recognition sequences enables directional control of the portion of the ORF that is sandwiched between the sites; the starting direction of these ORF fragments (which have become exons) determines the logical expression requirements of Cre and Flp (B,E). When the correct combinations of recombinases are present, the introns are excised during mRNA processing, producing a functional molecular tool (C,F).

Implementation

The following resources may be of interest for groups interesting in implementing intersectional experimental design.

Plasmids

In addition to EYFP and ChR2-EYFP, a large number of additional, validated molecular payloads in the INTRSECT configuration have been developed, including additional fluorophores, excitatory and inhibitory opsins, genetically-encoded calcium indicators, and rabies targeting genes.

Recombinases

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
55636pAAV-EF1a-CreNoneYes
55632pAAV-Ef1a-mCherry-IRES-CreNoneYes
55637pAAV-EF1a-FlpoNoneYes
55634pAAV-EF1a-mCherry-IRES-FlpoNoneYes
55638pAAV-EF1a-vCreNoneYes
55635pAAV-EF1a-sCreNoneNo
55633pAAV-EF1a-mCherry-IRES-DreNoneNo
183535pAAV-CaMKIIa-FlpoNoneNo

Single recombinase-dependent

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
55641pAAV-Ef1a-fDIO EYFPFlpYes
55640pAAV-Ef1a-dDIO hChR2(H134R)-EYFPDreNo
55639pAAV-Ef1a-fDIO hChR2(H134R)-EYFPFlpYes
126080pAAV-Ef1a-sCreDIO hChR2(H134R)-eYFPScreNo
126081pAAV-Ef1a-vCreDIO hChR2(H134R)-eYFPVcreNo

Dual recombinase-dependent: Fluorophores

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
55650pAAV-hSyn Con/Fon EYFPCre AND FlpYes
231926pAAV-Ef1a-Con/Fon-EYFPCre AND FlpNo
55651pAAV-hSyn Con/Foff EYFPCre AND NOT FlpF3/F5No
137162pAAV-Ef1a-Con/Foff 2.0-EYFPCre AND NOT FlpFRT/F5Yes
55652pAAV-hSyn Coff/Fon EYFPFlp AND NOT CreNo
231927pAAV-Ef1a-Coff/Fon-EYFPFlp AND NOT CreYes
137129pAAV-Ef1a-Con/Fon-BFPCre AND FlpYes
137130pAAV-Ef1a-Con/Foff 2.0-BFPCre AND NOT FlpFRT/F5Yes
137131pAAV-Ef1a-Coff/Fon-BFPFlp AND NOT CreYes
137132pAAV-Ef1a-Con/Fon-mCherryCre AND FlpYes
137133pAAV-Ef1a-Con/Foff 2.0-mCherryCre AND NOT FlpFRT/F5Yes
137134pAAV-Ef1a-Coff/Fon-mCherryFlp AND NOT CreYes
137135pAAV-Ef1a-oScarletNoneYes
137136pAAV-Ef1a-Con/Fon-oScarletCre AND FlpYes
137137pAAV-Ef1a-Con/Foff 2.0-oScarletCre AND NOT FlpFRT/F5Yes
137138pAAV-Ef1a-Coff/Fon-oScarletFlp AND NOT CreYes

Dual recombinase-dependent: GECI

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
137119pAAV-EF1a-Con/Fon-GCaMP6MCre AND FlpYes
137120pAAV-Ef1a-Con/Foff 2.0-GCaMP6MCre AND NOT FlpFRT/F5Yes
137121pAAV-Ef1a-Coff/Fon-GCaMP6MFlp AND NOT CreYes
137122pAAV-Ef1a-Con/Fon-GCaMP6FCre AND FlpYes
137123pAAV-Ef1a-Con/Foff 2.0-GCaMP6FCre AND NOT FlpFRT/F5Yes
137124pAAV-Ef1a-Coff/Fon-GCaMP6FFlp AND NOT CreYes
137125pAAV-Ef1a-sRGECONoneYes
137126pAAV-Ef1a-Con/Fon-sRGECOCre AND FlpYes
137127pAAV-Ef1a-Con/Foff 2.0-sRGECOCre AND NOT FlpFRT/F5Yes
137128pAAV-Ef1a-Coff/Fon-sRGECOFlp AND NOT CreYes

Dual recombinase-dependent: Excitatory Opsins

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
55645pAAV-hSyn Con/Fon hChR2(H134R)-EYFPCre AND FlpYes
55644pAAV-nEF Con/Fon hChR2(H134R)-EYFPCre AND FlpNo
55647pAAV-nEF Con/Foff hChR2(H134R)-EYFPCre AND NOT FlpF3/F5No
137163pAAV-nEF-Con/Foff 2.0-ChR2-EYFPCre AND NOT FlpFRT/F5Yes
55646pAAV-hSyn Con/Foff hChR2(H134R)-EYFPCre AND NOT FlpF3/F5No
55649pAAV-hnEF Coff/Fon hChR2(H134R)-EYFPFlp AND NOT CreNo
55648pAAV-hSyn Coff/Fon hChR2(H134R)-EYFPFlp AND NOT CreNo
137139pAAV-nEF-Con/Fon-ChR2(ET/TC)-EYFPCre AND NOT FlpYes
137140pAAV-nEF-Con/Foff 2.0-ChR2(ET/TC)-EYFPCre AND FlpFRT/F5Yes
137141pAAV-nEF-Coff/Fon-ChR2(ET/TC)-EYFPFlp AND NOT CreYes
137142pAAV-nEF-Con/Fon-ChR2-mCherryCre AND FlpYes
137143pAAV-nEF-Con/Foff 2.0-ChR2-mCherryCre AND NOT FlpFRT/F5Yes
137144pAAV-nEF-Coff/Fon-ChR2-mCherryFlp AND NOT CreYes
137145pAAV-nEF-Con/Fon-bREACHes-EYFPCre AND FlpNo
137146pAAV-nEF-Con/Foff 2.0-bREACHes-EYFPCre AND NOT FlpFRT/F5No
137147pAAV-nEF-Coff/Fon-bREACHes-EYFPFlp AND NOT CreNo
137158pAAV-nEF-ChRmine-mScarletNoneYes
137159pAAV-nEF-Con/Fon-ChRmine-oScarletCre AND FlpYes
137160pAAV-nEF-Coff/Fon-ChRmine-oScarletCre AND NOT FlpFRT/F5Yes
137161pAAV-nEF-Con/Foff 2.0-ChRmine-oScarletFlp AND NOT CreYes

Dual recombinase-dependent: Inhibitory Opsins

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
137148pAAV-nEF-Con/Fon-Arch3.3-p2a-EYFPCre AND FlpYes
137149pAAV-nEF-Con/Foff 2.0-Arch3.3-EYFPCre AND NOT FlpFRT/F5Yes
137150pAAV-nEF-Coff/Fon-Arch3.3-p2a-EYFPFlp AND NOT CreYes
137151pAAV-nEF-NpHR3.3-EYFPNoneW179FYes
137152pAAV-nEF-Con/Fon-NpHR3.3-EYFPCre AND FlpW179FYes
137153pAAV-nEF-Con/Foff 2.0-NpHR3.3-EYFPCre AND NOT FlpFRT/F5; W179FYes
137154pAAV-nEF-Coff/Fon-NpHR3.3-EYFPFlp AND NOT CreW179FYes
137155pAAV-nEF-Con/Fon-iC++-EYFPCre AND FlpYes
137156pAAV-nEF-Con/Foff 2.0-iC++-EYFPCre AND NOT FlpFRT/F5Yes
137157pAAV-nEF-Coff/Fon-iC++-EYFPFlp AND NOT CreYes

Dual recombinase-dependent: DREADDs

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
177669pAAV-nEF-Coff/Fon DREADD Gi-mCherryFlp AND NOT CreNo
177672pAAV-nEF-Con/Fon DREADD Gi-mCherryCre AND FlpYes
177673pAAV-nEF-Con/Foff DREADD Gi-mCherryCre AND NOT FlpYes
183532pAAV-nEF Con/Fon DREADD Gq-mCherryCre AND FlpNo
183533pAAV-nEF Con/Foff DREADD Gq-mCherryCre AND NOT FlpNo
183534pAAV-nEF Coff/Fon DREADD Gq-mCherryFlp AND NOT CreNo

Dual recombinase-dependent: Rabies-related

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
131779pAAV-nEF-Con/Fon TVA-mCherryCre AND FlpNo

Triple recombinase-dependent

Addgene ID Plasmid Logic Sites and Mutations In-Stock Viral Items
137164pAAV-nEF-Con/Fon/Von-EYFPCre AND Flp AND VcreYes
137165pAAV-Ef1a-Con/Fon/Von-GCaMP6MCre AND Flp AND VcreNo

References

  1. Fenno LE, Mattis J, Ramakrishnan C, Hyun M, Lee SY, He M, Tucciarone J, Selimbeyoglu A, Berndt A, Grosenick L, Zalocusky KA, Bernstein H, Swanson H, Perry C, Diester I, Boyce FM, Bass CE, Neve R, Huang ZJ, Deisseroth K. 2014. Targeting cells with single vectors using multiple-feature Boolean logic. Nat Methods 11(7):763-72. PubMed (Link opens in a new window)
  2. Chuhma N, Mingote S, Yetnikoff L, Kalmbach A, Ma T, Ztaou S, Sienna AC, Tepler S, Poulin JF, Ansorge M, Awatramani R, Kang UJ, Rayport S. 2018. Dopamine neuron glutamate cotransmission evokes a delayed excitation in lateral dorsal striatal cholinergic interneurons. Elife. 7. pii: e39786. PubMed (Link opens in a new window)
  3. Cummings KA, Clem RL. 2020. Prefrontal somatostatin interneurons encode fear memory. Nat Neurosci. 23(1):61-74. PubMed (Link opens in a new window)
  4. Hafner G, Witte M, Guy J, Subhashini N, Fenno LE, Ramakrishnan C, Kim YS, Deisseroth K, Callaway EM, Oberhuber M, Conzelmann KK, Staiger JF. 2019. Mapping Brain-Wide Afferent Inputs of Parvalbumin-Expressing GABAergic Neurons in Barrel Cortex Reveals Local and Long-Range Circuit Motifs. Cell Rep. 28(13):3450-3461. PubMed (Link opens in a new window)
  5. Mingote S, Amsellem A, Kempf A, Rayport S, Chuhma N. 2020. Dopamine-glutamate neuron projections to the nucleus accumbens medial shell and behavioral switching. Neurochemistry International 129:104482. PubMed (Link opens in a new window)
  6. Poulin JF, Caronia G, Hofer C, Cui Q, Helm B, Ramakrishnan C, Chan CS, Dombeck DA, Deisseroth K, Awatramani R. 2018. Mapping projections of molecularly defined dopamine neuron subtypes using intersectional genetic approaches. Nat Neurosci. 21(9):1260-1271. PubMed (Link opens in a new window)
  7. Rovira-Esteban L, Gunduz-Cinar O, Bukalo O, Limoges A, Brockway E, Müller K, Fenno L, Kim YS, Ramakrishnan C, Andrási T, Deisseroth K, Holmes A, Hájos N. 2019. Excitation of diverse classes of cholecystokinin interneurons in the basal amygdala facilitates fear extinction. eNeuro. 6(6). PubMed (Link opens in a new window)
  8. Wick ZC, Tetzlaff MR, Krook-Magnuson E. 2019. A novel population of long-range inhibitory neurons. Preprint (Link opens in a new window)
  9. Yu K, Ahrens S, Zhang X, Schiff H, Ramakrishnan C, Fenno L, Deisseroth K, Zhao F, Luo MH, Gong L, He M, Zhou P, Paninski L, Li B. 2017. The central amygdala controls learning in the lateral amygdala. Nat Neurosci. 20(12):1680-1685. PubMed (Link opens in a new window)
  10. Gao ZR, Chen WZ, Liu MZ, Chen XJ, Wan L, Zhang XY, Yuan L, Lin JK, Wang M, Zhou L, Xu XH, Sun YG. 2019. Tac1-Expressing Neurons in the Periaqueductal Gray Facilitate the Itch-Scratching Cycle via Article Tac1-Expressing Neurons in the Periaqueductal Gray Facilitate the Itch-Scratching Cycle via Descending Regulation. Neuron 101(1):45-59. PubMed (Link opens in a new window)
  11. Lazaridis I, Tzortzi O, Weglage M, Märtin A, Xuan Y, Parent M, Johansson Y, Fuzik J, Fürth D, Fenno LE, Ramakrishnan C, Silberberg G, Deisseroth K, Carlén M, Meletis K. 2019. A hypothalamus-habenula circuit controls aversion. Mol. Psychiatry 24(9):1351-1368. PubMed (Link opens in a new window)
  12. Mandelbaum G, Taranda J, Haynes TM, Hochbaum DR, Huang KW, Hyun M, Umadevi Venkataraju K, Straub C, Wang W, Robertson K, Osten P, Sabatini BL. 2019. Distinct Cortical-Thalamic-Striatal Circuits through the Parafascicular Nucleus. Neuron 102(3):636-652. PubMed (Link opens in a new window)
  13. Marcinkiewcz CA, Mazzone CM, D'Agostino G, Halladay LR, Hardaway JA, DiBerto JF, Navarro M, Burnham N, Cristiano C, Dorrier CE, Tipton GJ, Ramakrishnan C, Kozicz T, Deisseroth K, Thiele TE, McElligott ZA, Holmes A, Heisler LK, Kash TL. 2016. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature 537(7618):97-101. PubMed (Link opens in a new window)
  14. Tovote P, Esposito MS, Botta P, Chaudun F, Fadok JP, Markovic M, Wolff SB, Ramakrishnan C, Fenno L, Deisseroth K, Herry C, Arber S, Lüthi A. 2016. Midbrain circuits for defensive behaviour. Nature 534(7606):206-12. PubMed (Link opens in a new window)